Exiqon's qPCR Assays, MicroRNA Arrays Drive Q1 Sales Up 33 Percent

CEO Lars Kongsbak said that the Danish firm's menu of PCR assays is now the "biggest product line" that Exiqon offers, surpassing even its arrays.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.